Table 2. Distribution of causative pathogens.

NMDA: N-methyl-D-aspartate

Bacterial infection (n = 126, 79.74%)	Frequency (%)
Klebsiella pneumoniae	15 (11.90)
Escherichia coli	14 (11.11)
Staphylococcus aureus	13 (10.31)
Salmonella spp.	11 (8.73)
Streptococcus pneumoniae	11 (8.72)
Shigella spp.	9 (7.14)
Campylobacter spp.	7 (5.55)
Pseudomonas aeruginosa	6 (4.75)
Streptococcus agalactiae	6 (4.75)
Acinetobacter baumannii	5 (3.96)
Mycobacterium tuberculosis	4 (3.17)
Haemophilus influenzae	4 (3.17%)
Staphylococcus epidermidis	4 (3.17%)
Brucella spp.	3 (2.38%)
Micrococcus luteus	3 (2.37%)
Enterobacter aerogenes	2 (1.58%)
Others	9 (5.70%)
Viral infection (n = 21, 13.29%)	Frequency (%)
Herpes simplex virus	9 (42.85%)
Enterovirus	3 (14.28%)
Dengue virus	2 (9.52%)
Varicella zoster virus	2 (9.52%)
Cytomegalovirus	1 (4.76%)
West Nile virus	1 (4.76%)
Unknown virus	3 (14.28%)
Fungal infection (n = 6, 3.79%)	Frequency (%)
Candida spp.	6 (100%)
Auto-immune CNS Infection (5, 3.16%)	Frequency (%
Anti-NMDA	5 (100%)